Navigation Links
Titanium Group Announces Contract With Haitong Securities
Date:10/16/2007

income and research. Haitong now manages over US$2 billion for its clients and is the only domestic securities firm assigned "M2(China)" by Fitch ratings since 2005. For additional information, please visit http://www.htsec.com.

About Titanium Group:

Titanium Group, LTD (http://www.titanium-tech.com), and it's wholly owned subsidiary Titanium Technology, is a leading biometric and security solutions provider featuring its proprietary and patented automated Face Recognition Systems (AFRS). Titanium's AFRS products capture human face images electronically, input the facial images into searchable files (faceprint) and, in just seconds, accurately compare the facial images to a database containing millions of faces. These cutting-edge products reduce administration cost, enhance security, and significantly increase overall productivity. Titanium's products are distributed worldwide, either directly or through resellers or OEM partners, to governments, law enforcement agencies, gaming companies, and other organizations. The Company's clients include: IBM, Hong Kong Government and the Peoples Bank of China, etc.

Safe Harbor Provisions

Certain oral statements made by management from time to time and certain statements contained in press releases and periodic reports issued by Titanium Group, Ltd. (the "Company"), as well as those contained herein, that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934 and, because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements, including those in Management's Discussion and Analysis, are statements regarding the intent, belief or current expectations, estimates or projections of the Company, its
'/>"/>

SOURCE Titanium Group, Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology news :

1. UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints
2. Experiments provide proof of how traveling in groups protects insects
3. Experiments provide proof of how traveling in groups protects insects
4. Flocking together: Study shows how animal groups find their way
5. Virginia Tech group adds tools to DNA-targeted anti-cancer drugs
6. Group proves its possible to grow new lung alveoli by growing new blood vessels
7. New HIV study identifies high-risk subgroups of adolescents
8. UCLA study of community health project shows how group dynamics affect fitness, eating habits
9. Twenty of worlds 162 grouper species threatened with extinction
10. Gene study shows three distinct groups of chimpanzees
11. Wiley announces publication of Databasing the Brain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., The atomic-level action of a remarkable class o... researchers with the Lawrence Berkeley National L...protein crystallography beamline at the Advanced L...al roles in gene expression and replication, and a...as well as infectious agents, such as the human pa...
(Date:11/24/2009)..., What constitutes fish food is a matter of deba... that fish get almost 50 percent of their carbon f...nk between the terrestrial and aquatic ecosystems....ngton shows this is not likely to be true. Algae p...ic life, according to research published this week...
(Date:11/23/2009)..., Washington, D.C. The community-associated stra... bacteria resistant to most common antibioticspose...n and is making its way into hospitals, according ...ctious Diseases . , The new threat is easily pi...lic places and has increased the overall burden of...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 1California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 2Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 1Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 2Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 3Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 1Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 2Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 3Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 4
...fly? The fly,s secret in avoiding death in this wa...out of the way. "This kind of low-power decision-m...omously navigating robots", according to Gwyneth C... will be presenting her work on triggered escape r...nual Main Meeting in Barcelona, on Wednesday 13th ...
...e creation of reading matter, a "nano-printing" te...duction of nano-devices currently built one at a t...vation is the DNA microarray, a nano-device used t...s Alzheimer,s, viral illnesses such as AIDS, and c...uce these complex devices would make DNA analysis ...
...dard for treating newborns suffering from opiate w...ates themselves are superior to sedatives for trea...adone while pregnant. , Opiates appear to better "...potentially reduce the likelihood of seizures," ac...d Osborn, a neonatologist at the Royal Prince Alfr...
Other Biology News:New technique may speed DNA analysis 2Opiates Better Than Sedatives For Treating Newborns In Withdrawal 2
(Date:11/25/2009)...tochromatodayannouncedtheappointmentofPeterMoldt,P...kSporkastheNovoA/SrepresentativeontheCompany,sBoar...ers. ,, "WeareverypleasedtowelcomePeterMoldttot...andguidanceasCytochromacontinuestomakeprogressinbe...mpany,"statedAlanLewis,PhD,ChairmanofCytochroma,sB...
(Date:11/25/2009)...Call/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )announc...executiveofficer,willpresentatthePiperJaffray21stA...areasfollows:,PiperJaffray21stAnnualHealthCareCon...asternTime,Location:TheNewYorkPalaceHotel,NewYork,...ye/,target=,_blank,title=,http://www.corporate-ir...
(Date:11/24/2009)...also Visit Detroit , (Voc...ench Ambassador for International Investment, and ... , , ,What: Ambassador Appia is available to meet...ives adopted by France to further develop the fina...n and development., , ,When: Available for Intervi...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--DowAgroSciencesCanadaanno...isionofThompsonsLimitedofBlenheim,Ontario.Theaddit...urrentseedsbusinessasthecompanyanticipatestheintro...esHerbicideTolerantTraitTechnologyincornin2012.The... "Thisacquisitionbringstogethertwostrongprogressiv...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...e Growth Plan on Tuesday, May 20th, FREDERICK, Md...), the maker of the ActiPatch(TM), a drug free,ant...ated microchip,delivering weeks of continuous puls... it will hold a conference call to update investor...pany. Andrew Whelan, President and CEO of,BioElect...
...al, Inc., a,developer of innovative therapies in w... $49.5 million in Series D preferred stock financi...reeArch Partners and Skyline,Ventures also partici...articipation by existing investors Affinity Capita... Venture Partners, INVESCO Private Capital,JP Morg...
...n in 2008 -, FREMONT, Calif., May 15 Vermillion,...mpany, today announced financial,results for the f... update,on recent corporate and clinical developme...strated significant clinical,and commercialization...e,programs target significant unmet clinical needs...
Other Biology Technology:BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 2BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 3Novasys Medical Secures $49.5 Million in Series D Financing to Expand Commercialization of Its Renessa(R) Treatment for Incontinence in Women 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 3Vermillion Announces First Quarter 2008 Financial Results and Business Progress 4Vermillion Announces First Quarter 2008 Financial Results and Business Progress 5Vermillion Announces First Quarter 2008 Financial Results and Business Progress 6Vermillion Announces First Quarter 2008 Financial Results and Business Progress 7Vermillion Announces First Quarter 2008 Financial Results and Business Progress 8Vermillion Announces First Quarter 2008 Financial Results and Business Progress 9
Mouse Anti-TGE Virus peplomer Monoclonal Antibody, Unconjugated, Clone 1Q17 from Abcam
Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-14-3-3 tau Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Human ThPok Polyclonal Antibody, Unconjugated from Abcam
Biology Products: